SGLT-2 inhibitors, a diabetes drug class that includes drugs like canagliflozin (Invokana) have been shown to be beneficial for patients who have both type 2 diabetes and chronic kidney disease in regards to developing anemia. Read more
Studies suggest that rates of type 1 diabetes are higher among people who are transgender or gender diverse than among the general population. Read more
Obesity is a major risk factor for both cardiovascular disease and metabolic disorders like diabetes. Both BMI and waist circumference are frequently used as gauges of obesity; however, their relationship to weight loss’s effects on different health outcomes has not been well studied. A recent study adds data linking increases in one’s waist circumference to […]
Currently available closed loop insulin delivery systems (sometimes called the “artificial pancreas”) have made insulin dosing much easier for many people with diabetes. However, they still require users to monitor data and take various daily actions. One innovator is looking to develop a fully automated system that would not require any manual tasks, such as […]
Some diabetes patients may be finding an unexpected benefit in glucose management and health during the pandemic. These patients, finding themselves at home, with altered daily routines, and perhaps a decrease in workloads, may be able to start making small positive behavioral changes that can help their diabetes management. Read more
Gene therapy has so far been explored mainly in the treatment of rare diseases, but researchers are now turning to how it may be used to treat type 1 diabetes. Gene therapy advocates say the research could transform type 1 treatment, but the research is in its early stages and many obstacles need to be […]
Tirzepatide, a newer diabetes drug, has been shown to reduce patient hemoglobin A1c levels, as well as lowering body weight and improving insulin sensitivity markers in patients with type 2 diabetes. Read more
Some drugs used to lower glucose in patients with diabetes, such as metformin, SGLT2 inhibitors, and sulfonylureas, might have beneficial effects on COVID-19, potentially affecting the risk of progression to severe disease and death. Read more
The US Diabetes Prevention Program (DPP) multicenter trial established nearly 20 years ago that it is possible to delay or prevent prediabetes from progressing into full-blown type 2 diabetes. The DPP trial places greater emphasis on weight loss over physical activity, but is that emphasis in the right place? Diabetes exercise expert Dr. Sheri Colberg examines […]
Women who have obesity and polycystic ovarian syndrome (PCOS) have an increased risk of developing type 2 diabetes, researchers say. PCOS is experienced by up to 10% of women of reproductive age, and between 50% and 80% of women with PCOS have obesity. Read more
SGLT-2 inhibitors like sotagliflozin are antihyperglycemic agents approved in the US for use in patients with type 2 diabetes. However, sotagliflozin is also approved for type 1 diabetes in Europe, and studies have shown that using sotagliflozin along with insulin has benefits in patients with type 1 diabetes. Read more
Zegalogue will be sold as both an auto-injector, similar to an EpiPen, and a prefilled syringe, and will allow people with diabetes to quickly raise their blood sugars in an emergency situation. It is approved for adults and for children 6 and up, and is expected to launch in June 2021. Read more
Researchers have found that certain viral infections may increase the incidence of type 1 diabetes, and are now investigating whether COVID-19 is among them. Learning more about how viruses may lead to diabetes could help develop strategies for prevention. Read more
Type 1 diabetes can potentially increase the risk of miscarriage in some circumstances, and the hormonal changes surrounding a pregnancy ended due to miscarriage or abortion can also impact type 1 management. Read more
Research has found people who follow an intermittent fasting eating plan have increased adiponectin levels and decreased leptin levels in the body, which can help those struggling with insulin resistance. Read more
Researchers say there is convincing evidence that people with type 2 diabetes have an increased risk of developing Parkinson’s disease. Type 2 diabetes is also linked to faster disease progression in patients who already have Parkinson’s. Read more
The American Diabetes Association (ADA) recommends lowering the target hemoglobin A1C (HbA1C) guidelines for children with type 1 diabetes. This is due to the finding that chronically high blood glucose levels in children could lead to higher risk of several serious effects, including abnormal brain development and cardiac issues. Read more
Researchers say the time of day at which men with type 2 diabetes and obesity or overweight performed moderate-to-vigorous physical activity made a difference in their cardiovascular fitness and health risks. They did not find the same effect in women who participated in the study. Read more
Managing diabetes can be stressful, and lead to depression; in turn, depression can affect eating and exercise habits, and other factors that can change patient glycemic control. Recently, some studies have shown an association in patients with type 2 diabetes who have been diagnosed with depression and the incidence of dementia, and the role of […]
Aiotech company called Thermalin is working on a new type of ultra-fast insulin that will not require refrigerated storage. They are also developing a miniaturized closed loop device (also called an artificial pancreas system) called the StampPump. Read more